The Perlecan Fragment LG3 Is a Novel Regulator of Obliterative Remodeling Associated With Allograft Vascular Rejection

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Circulation Research

• Publication date

  2012-01-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCRESAHA.111.250431PMID 22076637
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Caspase-3-dependent export of TCTP: a novel pathway for antiapoptotic intercellular communication

  2011cited by this paper
• Intestinal ischemia reperfusion and lipopolysaccharide transform a tolerogenic signal into a sensitizing signal and trigger rejection

  2011cited by this paper
• Banff ’09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working Groups

  2010cited by this paper
• Caspase-3-mediated secretion of connective tissue growth factor by apoptotic endothelial cells promotes fibrosis

  2010cited by this paper
• Epidermal Growth Factor and Perlecan Fragments Produced by Apoptotic Endothelial Cells Co‐Ordinately Activate ERK1/2‐Dependent Antiapoptotic Pathways in Mesenchymal Stem Cells

  2010cited by this paper
• Matricryptic sites control tissue injury responses in the cardiovascular system: relationships to pattern recognition receptor regulated events.

  2010cited by this paper
• Intestinal Ischemia Reperfusion and Lipopolysaccharide Transform a Tolerogenic Signal into a Sensitizing Signal and Trigger Rejection

  2009cited by this paper
• Donor and Recipient Contribution to Transplant Vasculopathy in Chronic Renal Transplant Dysfunction

  2009cited by this paper
• Allograft Vasculopathy Versus Atherosclerosis Antibody and Complement in Transplant Vasculopathy Interferon- Axis in Graft Arteriosclerosis Vascular Remodeling in Transplant Vasculopathy Stem Cells and Transplant Arteriosclerosis Chemokines and Transplant Vasculopathy

  2008cited by this paper
• Caspase-3 Activation Triggers Extracellular Cathepsin L Release and Endorepellin Proteolysis*

  2008cited by this paper
• Kidney transplantation: mechanisms of rejection and acceptance.

  2008cited by this paper
• Urinary proteomic analysis of chronic allograft nephropathy

  2008cited by this paper
• Antisense extracellular signal‐regulated kinase‐2 gene therapy inhibits platelet‐derived growth factor‐induced proliferation, migration and transforming growth factor‐β1 expression in vascular smooth muscle cells and attenuates transplant vasculopathy

  2007cited by this paper
• Vascular injury and modulation of MAPKs: a targeted approach to therapy of restenosis.

  2007cited by this paper
• Endorepellin in vivo: targeting the tumor vasculature and retarding cancer growth and metabolism.

  2006cited by this paper
• Endothelial Apoptosis and Chronic Transplant Vasculopathy: Recent Results, Novel Mechanisms

  2006cited by this paper
• Perlecan Proteolysis Induces an α2β1 Integrin- and Src Family Kinase-dependent Anti-apoptotic Pathway in Fibroblasts in the Absence of Focal Adhesion Kinase Activation*

  2006cited by this paper
• Allograft Vasculopathy Versus Atherosclerosis

  2006cited by this paper
• Basement membrane proteoglycans: from cellar to ceiling

  2005cited by this paper
• BMP-1/Tolloid-like Metalloproteases Process Endorepellin, the Angiostatic C-terminal Fragment of Perlecan*

  2005cited by this paper
• Granzyme B Induces Endothelial Cell Apoptosis and Contributes to the Development of Transplant Vascular Disease

  2005cited by this paper
• Apoptosis of endothelial cells triggers a caspase‐dependent anti‐apoptotic paracrine loop active on vascular smooth muscle cells

  2004cited by this paper
• Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through α2β1 integrin

  2004cited by this paper
• clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification

  2002cited by this paper
• Goodpasture syndrome during the course of a Schönlein-Henoch purpura.

  2002cited by this paper
• Mechanisms of Chronic Renal Allograft Rejection. II. Progressive Allograft Glomerulopathy in Miniature Swine

  2002cited by this paper
• Leptin and renal disease.

  2002cited by this paper
• Paracrine repercussions of preconditioning on angiogenesis and apoptosis of endothelial cells.

  2002cited by this paper
• K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

  2002cited by this paper
• The role of collagen-derived proteolytic fragments in angiogenesis.

  2001cited by this paper
• Host bone-marrow cells are a source of donor intimal smooth- muscle–like cells in murine aortic transplant arteriopathy

  2001cited by this paper
• Molecular mechanisms in intimal hyperplasia

  2000cited by this paper
• CD8+ T lymphocytes mediate destruction of the vascular media in a model of chronic rejection.

  2000cited by this paper
• Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice.

  2000cited by this paper
• von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.

  1998cited by this paper
• Human transplant coronary artery disease: pathological evidence for Fas-mediated apoptotic cytotoxicity in allograft arteriopathy.

  1996cited by this paper
• Development of a mouse aortic transplant model of chronic rejection

  1995cited by this paper
• Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMM.

  1995cited by this paper

• Non-HLA Antibodies in Kidney Transplantation: Pathogenesis, Clinical Impact, and Management Approaches

  2025cites this paper
• Proteoglycans of basement membranes: Crucial controllers of angiogenesis, neurogenesis, and autophagy.

  2024cites this paper
• Soluble Proteoglycans and Proteoglycan Fragments as Biomarkers of Pathological Extracellular Matrix Remodeling

  2024cites this paper
• Immune surveillance and humoral immune responses in kidney transplantation – A look back at T follicular helper cells

  2023cites this paper
• Autoantibodies against DNA-topoisomerase I promote renal allograft rejection by increasing alloreactive T cell responses.

  2023cites this paper
• Donor–Recipient Non-HLA Variants, Mismatches and Renal Allograft Outcomes: Evolving Paradigms

  2022cites this paper
• Microvascular Inflammation of the Renal Allograft: A Reappraisal of the Underlying Mechanisms

  2022cites this paper
• Non-HLA Antibodies in Kidney Transplantation: Immunity and Genetic Insights

  2022cites this paper
• Extracellular Vesicles Mediate Immune Responses to Tissue-Associated Self-Antigens: Role in Solid Organ Transplantations

  2022cites this paper
• Autophagy, tissue repair, and fibrosis: a delicate balance.

  2021cites this paper
• Autoantibodies to LG3 are associated with poor long‐term survival after liver retransplantation

  2021cites this paper
• Increased Autoantibodies Against Ro/SS-A, CENP-B, and La/SS-B in Patients With Kidney Allograft Antibody-mediated Rejection

  2021cites this paper
• The emerging field of non-HLA-antibodies in transplant medicine and beyond.

  2021cites this paper
• Apoptotic exosome-like vesicles regulate endothelial gene expression, inflammatory signaling, and function through the NF-κB signaling pathway

  2020cites this paper
• Non-HLA Abs in Solid Organ Transplantation

  2020cites this paper
• Autoantibodies Against Ro/SS-A, CENP-B, and La/SS-B are Increased in Patients with Kidney Allograft Antibody-Mediated Rejection

  2020cites this paper
• Discovery of non‐HLA antibodies associated with cardiac allograft rejection and development and validation of a non‐HLA antigen multiplex panel: From bench to bedside

  2020cites this paper
• Impact and production of Non‐HLA‐specific antibodies in solid organ transplantation

  2020cites this paper
• WITHDRAWN: [Non anti-HLA antibodies and acute rejection: A critical viewpoint].

  2019cites this paper
• Injury derived autoimmunity: Anti-perlecan/LG3 antibodies in transplantation.

  2019cites this paper
• Sensitization to endothelial cell antigens: Unraveling the cause or effect paradox.

  2019cites this paper
• Compelling scientific and clinical evidence that non-HLA specific antibodies impact graft outcome independently and in concert with donor HLA specific antibodies.

  2019cites this paper
• Kidney involvement in systemic sclerosis: From pathogenesis to treatment

  2018cites this paper
• Relevance of Non-HLA Antibodies in Transplantation

  2018cites this paper
• Non-HLA Antibodies in Renal Transplantation, Where Do We Stand?

  2018cites this paper
• Pretransplant IgA-Anti-Beta 2 Glycoprotein I Antibodies As a Predictor of Early Graft Thrombosis after Renal Transplantation in the Clinical Practice: A Multicenter and Prospective Study

  2018cites this paper
• Graft versus Host Disease: From Basic Pathogenic Principles to DNA Damage Response and Cellular Senescence

  2018cites this paper
• Endothelial Dysfunction in Kidney Transplantation

  2018cites this paper
• Protein biomarkers in renal transplantation

  2018cites this paper
• OBSOLETE: Transplant Arteriosclerosis

  2018cites this paper
• Defining the phenotype of antibody-mediated rejection in kidney transplantation: Advances in diagnosis of antibody injury.

  2017cites this paper
• Immunological Risk Stratification by Assessing Both the HLA and Non-HLA-Specific Antibodies: Time to Include Testing for Non-HLA Antibodies in the Routine Clinical Antibody Analysis Profile?

  2017cites this paper
• Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection

  2017cites this paper
• Endothelial Cells in Antibody-Mediated Rejection of Kidney Transplantation: Pathogenesis Mechanisms and Therapeutic Implications

  2017cites this paper
• New Insights into the Role of Basement Membrane-Derived Matricryptins in the Heart.

  2017cites this paper
• Ventricular assist device elicits serum natural IgG that correlates with the development of primary graft dysfunction following heart transplantation.

  2017cites this paper
• Impact of Non-Human Leukocyte Antigen-Specific Antibodies in Kidney and Heart Transplantation

  2017cites this paper
• Danger signals in regulating the immune response to solid organ transplantation

  2017cites this paper
• The Emerging Importance of Non-HLA Autoantibodies in Kidney Transplant Complications.

  2017cites this paper
• Microenvironmental Effects of Cell Death in Malignant Disease.

  2016cites this paper
• The importance of non-HLA antibodies in transplantation

  2016cites this paper
• Pathogenesis of non-HLA antibodies in solid organ transplantation: Where do we stand?

  2016cites this paper
• Clinical and immunological relevance of antibodies in solid organ transplantation

  2016cites this paper
• Non-HLA antibodies against endothelial targets bridging allo- and autoimmunity.

  2016cites this paper
• Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells.

  2016cites this paper
• Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients. Part I. In vivo imaging methods

  2016cites this paper
• Anti‐LG3 Antibodies Aggravate Renal Ischemia–Reperfusion Injury and Long‐Term Renal Allograft Dysfunction

  2016cites this paper
• Clinical value of non-HLA antibodies in kidney transplantation: Still an enigma?

  2016cites this paper
• Local Augmented Angiotensinogen Secreted from Apoptotic Vascular Endothelial Cells Is a Vital Mediator of Vascular Remodelling

  2015influential citation
• The role of perlecan and endorepellin in the control of tumor angiogenesis and endothelial cell autophagy

  2015cites this paper
• Immune-Mediated Vascular Injury and Dysfunction in Transplant Arteriosclerosis

  2015cites this paper
• The 20S proteasome core, active within apoptotic exosome-like vesicles, induces autoantibody production and accelerates rejection

  2015cites this paper
• Mouse model of alloimmune-induced vascular rejection and transplant arteriosclerosis.

  2015cites this paper
• Proteoglycan form and function: A comprehensive nomenclature of proteoglycans

  2015cites this paper
• The Perlecan Fragment LG3 Regulates Homing of Mesenchymal Stem Cells and Neointima Formation During Vascular Rejection

  2015cites this paper
• Decoding the Matrix: Instructive Roles of Proteoglycan Receptors.

  2015cites this paper
• Vascular remodeling in pulmonary hypertension

  2015cites this paper
• Mechanisms of Renal Graft Chronic Injury and Progression to Interstitial Fibrosis

  2015cites this paper
• RIPK3 Regulates Microvascular Endothelial Cell Necroptosis and Cardiac Allograft Rejection

  2014cites this paper
• Impact of donor-specific antibodies on the outcomes of kidney graft: Pathophysiology, clinical, therapy.

  2014cites this paper
• Transcriptional complexity of the HSPG2 gene in the human mast cell line, HMC-1.

  2014cites this paper
• The identification of three novel biomarkers of major adverse kidney events.

  2014cites this paper
• The role of vascular-derived perlecan in modulating cell adhesion, proliferation and growth factor signaling.

  2014cites this paper
• LG3 fragment of endorepellin is a possible biomarker of severity in IgA nephropathy

  2013cites this paper
• Antiperlecan Antibodies Are Novel Accelerators of Immune‐Mediated Vascular Injury

  2013cites this paper
• Non-HLA antibodies in solid organ transplantation: recent concepts and clinical relevance

  2013cites this paper
• CT perfusion technique for assessment of early kidney allograft dysfunction: preliminary results

  2013cites this paper
• Mast Cells Produce Novel Shorter Forms of Perlecan That Contain Functional Endorepellin

  2012cites this paper
• The Molecular Legacy of Apoptosis in Transplantation

  2012influential citation